Maverex Limited


Prime Global are healthcare communications experts, offering integrated services across the breadth of Evidence and Access, including real-world evidence, health economics, evidence reviews, and market access.
With a global team based across the US, UK, and Europe, Prime Global’s Evidence and Access services combine years of specialist expertise from HCD Economics, an academically aligned organisation focusing on health economics and outcomes research (HEOR), with Prime Access, a market access and value communications consultancy.

Our combination of evidence generation and analytical expertise with specialist medical, patient, and payer communications skills helps you ensure patients have timely access to innovative treatments.

For pharmaceutical and biotechnology companies, we help shape the narrative, translating science into compelling value propositions that resonate with stakeholders across healthcare systems. For payers and policy makers, we empower the best value choices, providing a clear, coherent basis for decisions that can support the right access for patients.

Attending EPA 2023 are Sue O’Leary, SVP Prime Access (, Rebecca Massey, Senior Director, Global Market Access ( and Alison Rose, RWE Director ( Contact them today to find out more or arrange a meeting!


Get Involved 

To Sponsor Or Exhibit

David Boore
+44 20 8164 3052

To Speak

Francesca Wiggins

Marketing Opportunities

Diana Cobzac